Issues in Randomization

What is Randomization?

Random allocation means each patient has a known chance, usually equal, of being given each treatment, but the treatment is unpredictable.
Proper randomization creates comparable study groups at baseline.
With comparable groups, outcome differences can be attributed to treatment efficacy.
Randomness differs from haphazard allocation.
Two-armed trial: half receive investigational treatment, half receive control.
Crossover trial: participants receive all treatments in a randomized order.
Ethics of randomization relies on equipoise: uncertainty about treatment effectiveness.

Prevents investigator bias in creating study groups.
Makes study groups comparable on known and unknown baseline characteristics.
Keeps treatment allocation free from bias (selection bias).
Vital for masking treatment from participants and staff (blinding).
Protects trial results from investigator and patient response bias.
Ensures baseline differences arise by chance; probability theory allows calculation of likelihood of imbalances.
Increases likelihood of comparability regarding known and unknown confounders.
Provides a statistical basis for tests of significance.

Sir Ronald Alymer Fisher developed the randomized experiment in 1926 for agricultural experiments.
First randomized clinical trial: 1948 MRC study on streptomycin for tuberculosis.
MRC statistician Sir Austin Bradford Hill credited with the randomized design and concealment of treatment assignment.
1931: Doull et al. used colored dice for treatment allocation in a trial on irradiation for preventing the common cold.
1941: Bell reported on what is perhaps the first controlled trial to have documented the use of randomization.
Amberson et al. (1931) used a coin toss to assign groups to treatment or control after creating comparable groups.
The randomized controlled trial is the gold standard for evaluating new interventions.

Goal: Choose outcomes in a fair, unpredictable manner.
Simple Randomization:
- Each participant is randomly assigned to a treatment with a known probability.
- A typical design would give each treatment arm equal probability.
- May yield unequal group sizes, especially in small trials.
Block Randomization:
- Ensures a prespecified proportion of participants in each group after a certain enrollment number.
- Also called permuted block randomization.
- Keeps study group proportions close to desired at all times.
- Guarantees balance only when a block of treatment assignments is completed.
- Variable, randomly chosen block sizes provide additional concealment.
Stratified Randomization:
- Used to achieve balance on important characteristics (potential confounders).
- Separate block randomizations for each subgroup or stratum.
- Commonly used strata: clinical center, age, sex, medical history.
- Limit the number of strata to avoid sparse cells.
Pseudorandomization Methods:
- Nonrandom systematic schemes (e.g., odd/even admission days) should be avoided.
- They allow prediction of treatment assignment and compromise blinding.

Proper implementation maintains trial integrity.
The CONSORT statement provides guidelines for reporting clinical trials.
Hallmarks of sound allocation schemes:
- Reproducibility of allocation order.
- Documentation of methods.
- Prevention of treatment assignment release until entry conditions are met.
- Masking of assignment.
- Inability to predict future assignments.
- Procedures for monitoring protocol departures.
Sound allocation schemes prevent revealing treatment assignment until essential conditions are satisfied.
Intent-to-treat (ITT) principle: Participants must be analyzed as part of their assigned group, regardless of treatment received.

Random numbers are typically generated with computer software.
Statistical software can generate random numbers in the unit interval between 0 and 1.
Permuted block randomization involves assigning short sets or blocks of treatment.
Stratified randomization can be accomplished by performing block randomization in each center separately.

Should be done by individuals not involved in the study conduct.
Frequency of allocation and baseline characteristics should be routinely monitored.
Problems in implementation may invalidate trial results.

Adaptive Randomization Methods:
- Treatment assignment probabilities change over time based on enrolled participants.
- Biased coin randomization adjusts assignment probability based on current balance between treatment arms.
- Minimization: Treatment that minimizes imbalance is automatically assigned.
- Response-adaptive allocation: More successful treatments receive a greater probability of being assigned.
- Dynamic allocation can have increased complexity in implementation and analysis.

Documentation of randomization list is crucial, particularly in double-blinded trials.
Responsibilities for documenting the randomization list will typically be shared among multiple individuals.
Care should be given to properly document participant identifiers, time of enrollment, and treatment assignment.
An independent data center should house the database with treatment assignment information.

Excluding participants from the final analysis due to non-adherence to protocol can be problematic.
Missing outcome data can negatively impact statistical power, reliability, and acceptability of trial results.

Randomization protects against biases.
Allows valid tests to make treatment-related difference.
Randomization is a vital part of the blinding mechanism.
Permuted block designs with stratification by site are excellent ways to perform random allocation.
Nonrandomized trials are more difficult to interpret and keep free of bias.
Fixed allocation randomization algorithms are currently the most accepted and widely used method for treatment allocation in clinical research.